Site-Specific Phosphoproteomic Profiling of CAV1 Reveals Co-Regulatory Kinase Networks in Cancer Signaling Chrysilla Espy Vaz, Manasa Suresh, Leona Dcunha, Rajesh Raju, Saptami Kanekar International Journal of Molecular Sciences, 2026 Caveolin-1 (CAV1) is a 21 kDa Vesicular Integral-membrane Protein essential for the biogenesis of caveolae, invaginations of the plasma membrane that coordinate membrane trafficking, lipid homeostasis, and signal transduction. CAV1 functions as a scaffolding platform that integrates mechanotransduction, endocytosis, and cellular stress responses, thereby modulating vascular integrity, inflammation, metabolism, and tumorigenesis. To comprehensively understand the phosphorylation landscape of CAV1, global phosphoproteomic datasets and their corresponding experimental metadata were systematically curated and integrated from previously published human cellular studies. The phosphorylation sites with the highest detection frequency across these datasets were considered predominant phosphorylation sites. To assess their functional relevance, phosphosites in other proteins (PsOPs) co-regulated with the predominant CAV1 sites, along with their upstream kinases and high-confidence protein–protein interaction partners, were systematically analyzed. Analysis of global human cellular phosphoproteome datasets revealed that tyrosine 14 (Y14) and serine 37 (S37) of CAV1 are the most frequently detected phosphosites across diverse experimental conditions. Notably, many of the co-regulated proteins obtained were associated with carcinogenesis, apoptosis, and cell cycle regulation, including MET and ERBB2. Our analysis revealed SRC, ABL2, ERBB2, ERBB3, LYN, and TEC as potential upstream kinases of CAV1_Y14, whereas CSNK1E and GRK5 were predicted to regulate CAV1_S37. Considering the challenges associated with site-specific interrogation, we employed a global co-regulation analysis approach to characterize CAV1 phosphorylation dynamics. Our findings reveal that key CAV1 phosphosites modulate oncogenic signaling, cytoskeletal remodeling, and membrane organization, providing novel insights into CAV1-mediated cellular functions and its context-dependent role in tumor progression.
Neuromedin U Signaling Map: Toward Neuropeptide Focused Therapeutic Targets in Cancer and Human Diseases Leona Dcunha, Bhavana Edakkad, Isha Fathima, Shobha Dagamajalu, Rajesh Raju, Rex Devasahayam Arokia Balaya, Saptami Kanekar Omics A Journal of Integrative Biology, 2026 Neuropeptides play pivotal roles in intercellular communication in the nervous system and peripheral tissues. However, the molecular events underlying their signaling lack a unified representation in the scientific literature. A case in point is Neuromedin U (NMU), a neuropeptide structurally conserved across diverse species with multifaceted roles in integrating metabolic, immune, and stress signaling. Dysregulation of NMU signaling has been correlated to neuronal functions and various metabolic disorders, and is associated with colorectal, breast, and pancreatic cancers. Despite growing interest in NMU as a disease-associated signaling neuropeptide, a comprehensive and standardized schematic representation of its signaling pathway is lacking. We report here a NMU signaling map by systematically curating the literature and classifying NMU signaling events according to known pathway standards. The NMU signaling map included seven activation/inhibition events, 16 enzyme catalysis events, 66 gene regulation events, 30 protein expression events, and 20 translocation events. This NMU signaling map offers a new molecular framework and possibilities for biomarker and drug discovery and development, owing to its relevance in neuronal functions, inflammatory, metabolic, and oncogenic pathways. By consolidating fragmented evidence into a standardized pathway representation, this study serves as a resource for future integrative analyses, hypothesis generation, and translational research toward NMU signaling and neuropeptide-focused therapeutics innovation in cancer and human diseases.
Role of DEAD/DEAH-box helicases in immunity, infection and cancers Rex Devasahayam Arokia Balaya, Saptami Kanekar, Shreya Kumar, Richard K. Kandasamy Cell Communication and Signaling, 2025 DEAD/DEAH-box helicases (DDX) are integral RNA-binding proteins within the RNA helicase superfamily 2 (SF2), characterized by distinct DEAD (Asp-Glu-Ala-Asp) and DEAH (Asp-Glu-Ala-His) motifs. These motifs delineate two subfamilies: DEAD-box (DDX) and DEAH-box (DHX). DEAD-box proteins predominantly facilitate localized non-processive RNA duplex destabilization, whereas DEAH-box helicases mediate processive RNA translocation and unwinding. This functional dichotomy is attributed to Asp-to-His substitution in the DEAH motif, which modulates ATP hydrolysis and conformational dynamics. DEAD-box helicases have been implicated in critical cellular processes, including translation, splicing, and RNA decay. In contrast, DEAH-box proteins play pivotal roles in splicing, ribosome biogenesis, and RNA export. DEAD/DEAH-box helicases play crucial roles in various cellular processes, and their regulation is primarily governed by post-translational modifications (PTMs) and protein-protein interactions (PPIs), particularly within their N- and C-terminal sequences. Despite extensive research, significant knowledge gaps persist regarding their regulation, cofactor roles, substrates, PPIs, mutation effects, and involvement in signaling cascades. Mutations in DEAD domains have been associated with dysregulated immune signaling and have been implicated in various cancers, underscoring their importance in disease pathogenesis. Specific helicases, including DDX3, DDX5, DDX6, and DDX41, have been extensively studied for their roles in immune response regulation, antiviral defense, and cellular stress response. This review critically examines the DEAD-box helicases involved in cell cycle regulation and their inhibitors, as well as those that regulate the Toll-like receptor signaling pathway. Furthermore, we provide comprehensive insights into the phosphorylation-based regulation of major DDX members, with a particular focus on DDX3X, DDX21, and DDX42 in various cancers. Elucidating the molecular mechanisms, regulatory influences, and therapeutic potential of DEAD/DEAH-box helicases is of paramount importance, particularly in the fields of infectious diseases and immune modulation. This review provides current knowledge and identifies critical areas for future research, aiming to advance our understanding of these essential molecular machines and their potential as therapeutic targets.
ProteoArk: A One-Pot Proteomics Data Analysis and Visualization Tool for Biologists Mahammad Nisar, Sreelakshmi Pathappillil Soman, Sourav Sreelan, Levin John, Sneha M. Pinto, Richard Kumaran Kandasamy, Yashwanth Subbannayya, Thottethodi Subrahmanya Keshava Prasad, Saptami Kanekar, Rajesh Raju, Rex Devasahayam Arokia Balaya Journal of Proteome Research, 2025 ProteoArk is a web-based tool that offers a range of computational pipelines for comprehensive analysis and visualization of mass spectrometry-based proteomics data. The application comprises four primary sections designed to address various aspects of mass spectrometry data analysis in a single platform, including label-free and labeled samples (SILAC/iTRAQ/TMT), differential expression analysis, and data visualization. ProteoArk supports postprocessing of Proteome Discoverer, MaxQuant, and MSFragger search results. The tool also includes functional enrichment analyses such as gene ontology, protein-protein interactions, pathway analysis, and differential expression analysis, which incorporate various statistical tests. By streamlining workflows and developing user-friendly interfaces, we created a robust and accessible solution for users with basic bioinformatics skills in proteomic data analysis. Users can easily create manuscript-ready figures with a single click, including principal component analysis, heatmaps (K-means and hierarchical), MA plots, volcano plots, and circular bar plots. ProteoArk is developed using the Django framework and is freely available for users [https://ciods.in/proteoark/]. Users can also download and run the standalone version of ProteoArk using Docker as described in the instructions [https://ciods.in/proteoark/dockerpage]. The application code, input data, and documentation are available online at https://github.com/ArokiaRex/proteoark. A tutorial video is available on YouTube: https://www.youtube.com/watch?v=WFMKAZ9Slq4&ab_channel=RexD.A.B.
Cancer Signaling Networks and the Phosphoregulatory Role of RAF1 Kinase Leona Dcunha, Bhavana Edakkad, Mejo George, Diya Sanjeev, Levin John, Tanuja Yandiger, Mahammad Nisar, Pahal Priyanka, Athira Perunelly Gopalakrishnan, Rajesh Raju, Saptami Kanekar, Rex Devasahayam Arokia Balaya OMICS A Journal of Integrative Biology, 2025 Cancer signaling networks play key roles in cancer pathogenesis and drug discovery. The RAS/RAF/MAPK pathway has a crucial role in cell biology and cancer progression, with Raf-1 proto-oncogene, serine/threonine kinase (RAF1) serving as a key regulatory protein in this pathway. This study presents a comprehensive analysis of site-specific phosphorylation of RAF1 and its potential implications in cancer development and therapeutics. Through comprehensive analysis of human cellular phosphoproteomic datasets (769 qualitatively profiled and 196 quantitatively differentially expressed), we identified 63 phosphorylation sites on RAF1. Among these, 29 sites demonstrated distinct regulatory effects in various contexts, including cancer, infections, and signaling-related studies. Notably, our analysis revealed that the most prevalent phosphorylation sites, S259, S621, S642, S296, S301, and S43 primarily regulate kinase-independent RAF1 signaling. This observation suggests a complex interplay between phosphorylation events and RAF1 function, beyond its canonical kinase activity. By elucidating these regulatory mechanisms, our study provides valuable insights into the intricate regulation of RAF1 and its potential impact on cancer-related signaling pathways. These findings not only advance the current understanding of RAF1 regulation but also open new possibilities for the development of targeted therapeutic interventions for cancer treatment. Further investigation of these phosphorylation sites and their functional consequences may lead to novel strategies for cancer treatment innovation by modulating RAF1 activity in cancer cells.
Phosphoregulation for Therapeutic Interventions in Cancer? Phosphoregulatory Map of Checkpoint Kinase 1 (CHK1) Uncovers Unexplored Regulatory Layers Mejo George, Leona Dcunha, Levin John, Althaf Mahin, Diya Sanjeev, Athira Perunelly Gopalakrishnan, Mahammad Nisar, Prathik Basthikoppa Shivamurthy, Thottethodi Subrahmanya Keshava Prasad, Saptami Kanekar, Anoop Kumar G. Velikkakath, Rajesh Raju OMICS A Journal of Integrative Biology, 2025 Checkpoint kinase 1 (CHEK1/CHK1) is a serine/threonine kinase that is pivotal in maintaining genomic stability by regulating DNA replication, mitotic progression, and DNA damage response (DDR). Phosphorylation at distinct regulatory sites of CHK1 serves as a central signaling switch that tightly coordinates checkpoint control and DNA repair pathways. However, the broad phosphorylation network associated with the DNA repair pathway and CHK1 phosphorylation remains relatively underexplored, representing an untapped avenue with profound therapeutic potential. To bridge this discovery gap, we systematically analyzed global phosphoproteome datasets to visualize CHK1 phosphosites and their coregulated protein phosphosites, providing new insights into the functional networks governed by DDR signaling. The integrative analysis of 577 qualitative and 120 quantitative cellular phosphoproteomic datasets identified signatures of the CHK1 phosphorylation landscape. Our study visualized a strong co-occurrence of DDR-associated phosphosites in proteins, particularly with S280, and the Ataxia telangiectasia and Rad3-related protein-dependent S317 phosphosites in CHK1 located outside its kinase domain. Their coregulation analysis across CHK1 substrates, kinase regulators, and protein interactions uncovered connectivity between CHK1 phosphosites and DDR regulators. Collectively, our phosphosite-concordance approach reported here provides a regulatory map of CHK1 phosphorylation patterns, uncovering unexplored regulatory layers, and highlights new opportunities to explore mechanistic insights into CHK1 phosphoregulation as a target for therapeutic interventions in cancer.
Deciphering the Receptor-Mediated Signaling Pathways of Interleukin-19 and Interleukin-20 Vineetha Shaji, Shobha Dagamajalu, Diya Sanjeev, Mejo George, Saptami Kanekar, Ganesh Prasad, Thottethodi Subrahmanya Keshava Prasad, Rajesh Raju, Rex Devasahayam Arokia Balaya Journal of Interferon and Cytokine Research, 2024 Interleukin-19 (IL-19) and Interleukin-20 (IL-20) are inflammatory cytokines belonging to the IL-10 family with immunoregulatory properties. Emerging evidence highlights the importance of association of these cytokines with both immunological and inflammatory disorders, including chronic inflammation, cardiac dysfunction, and cancer. IL-19 and IL-20 bind to the heterodimeric receptor complex and induce multiple downstream signaling cascades by activating the signal transducer and activator of transcription 3 (STAT3), Jun N-terminal kinase (JNK), extracellular signal-regulated kinase (ERK), AKT serine/threonine kinase 1 (AKT1), and NFKB inhibitor alpha (NFKBIA), leading to proinflammatory and anti-inflammatory reactions in cancer, inflammation, tumor microenvironment, and infectious diseases. Considering the significant role of these cytokines, we integrated its cellular signaling network by combining multiomics molecular events associated with 56 molecules of induced by IL-19 and 156 molecules of by IL-20. The reactions of these signaling events are classified into enzyme catalysis/post-translational modifications, activation/inhibition events, molecular associations, gene regulations at the mRNA and protein level, and the protein translocation events. We believe that this signaling pathway map would serve as a knowledge base, that aid researchers and clinicians to understand and explore the intricate mechanisms and identify novel signaling components and therapeutic targets for diseases associated with dysregulated IL-19 and IL-20 signaling.
A global phosphosite-correlated network map of Thousand And One Kinase 1 (TAOK1) Pahal Priyanka, Athira Perunelly Gopalakrishnan, Mahammad Nisar, Prathik Basthikoppa Shivamurthy, Mejo George, Levin John, Diya Sanjeev, Tanuja Yandigeri, Sonet D. Thomas, Ahmad Rafi, Shobha Dagamajalu, Anoop Kumar G. Velikkakath, Chandran S. Abhinand, Saptami Kanekar, Thottethodi Subrahmanya Keshava Prasad, Rex Devasahayam Arokia Balaya, Rajesh Raju International Journal of Biochemistry and Cell Biology, 2024
Site-Specific Phosphoproteomic Profiling of CAV1 Reveals Co-Regulatory Kinase Networks in Cancer Signaling CE Vaz, M Suresh, L Dcunha, R Raju, S Kanekar International Journal of Molecular Sciences 27 (10), 4326 , 2026 2026
Computational phosphoproteomic insights into predominant BRAF phosphosites and associated regulatory networks in cancer L Dcunha, B Edakkad, L John, PB Shivamurthy, P Bera, D Das, R Raju, ... Biochimica et Biophysica Acta (BBA)-Proteins and Proteomics, 141141 , 2026 2026
Phytochemical Profiling and Biological Assessment of Curcuma aromatica Using UPLC-MS, In silico, and In vitro Approaches for Acne Treatment MGA Sandhya Vasanth, Amal Fahma, Saptami Kanekar, Rajesh Raju, Niyas Rehman Indian Journal of Pharmaceutical Education and Research 60 (3), 1081-1095 , 2026 2026
Neuromedin U Signaling Map: Toward Neuropeptide Focused Therapeutic Targets in Cancer and Human Diseases L Dcunha, B Edakkad, I Fathima, S Dagamajalu, R Raju, ... OMICS: A Journal of Integrative Biology 30 (4), 211-223 , 2026 2026
Phosphoregulation for Therapeutic Interventions in Cancer? Phosphoregulatory Map of Checkpoint Kinase 1 (CHK1) Uncovers Unexplored Regulatory Layers M George, L Dcunha, L John, A Mahin, D Sanjeev, AP Gopalakrishnan, ... OMICS: A Journal of Integrative Biology 30 (2), 105-119 , 2026 2026 Citations: 1
Cancer Signaling Networks and the Phosphoregulatory Role of RAF1 Kinase L Dcunha, B Edakkad, M George, D Sanjeev, L John, T Yandiger, M Nisar, ... OMICS: A Journal of Integrative Biology 29 (10), 486-501 , 2025 2025 Citations: 1
Role of DEAD/DEAH-box helicases in immunity, infection and cancers R Devasahayam Arokia Balaya, S Kanekar, S Kumar, RK Kandasamy Cell Communication and Signaling 23 (1), 292 , 2025 2025 Citations: 12
ProteoArk: A one-pot proteomics data analysis and visualization tool for biologists M Nisar, SP Soman, S Sreelan, L John, SM Pinto, RK Kandasamy, ... Journal of proteome research 24 (3), 1008-1016 , 2025 2025 Citations: 5
Navigating Effective Therapeutic Strategies for Dermatophytosis SKZF Mohammed Gulzar Ahmed, Prajitha Biju, Manjunath M Shenoy, Abdul Rehaman ... Journal of Young Pharmacists 17 ((1)), 7-12. , 2025 2025 Citations: 2
Computational discovery of novel FYN kinase inhibitors: a cheminformatics and machine learning-driven approach to targeted cancer and neurodegenerative therapy D Gopal, R Muthuraj, RDA Balaya, S Kanekar, I Ahmed, ... Molecular Diversity 28 (6), 4343-4359 , 2024 2024 Citations: 10
Elucidating the phosphoregulatory network of predominant phosphosite in AXL kinase: An integrative bioinformatic approach L John, M George, L Dcunha, M Nisar, D Sanjeev, P Pahal, ... Journal of Proteins and Proteomics 15 (3), 429-447 , 2024 2024 Citations: 8
Exploring the phospho-landscape of NEK6 kinase: Systematic annotation of phosphosites and their implications as biomarkers in carcinogenesis D Sanjeev, S Mendon, M George, L John, A Perunelly Gopalakrishnan, ... Journal of Proteins and Proteomics 15 (3), 377-393 , 2024 2024 Citations: 6
Deciphering the receptor-mediated signaling pathways of interleukin-19 and interleukin-20 V Shaji, S Dagamajalu, D Sanjeev, M George, S Kanekar, G Prasad, ... Journal of Interferon & Cytokine Research 44 (9), 388-398 , 2024 2024 Citations: 6
A global phosphosite-correlated network map of Thousand And One Kinase 1 (TAOK1) P Priyanka, AP Gopalakrishnan, M Nisar, PB Shivamurthy, M George, ... The International Journal of Biochemistry & Cell Biology 170, 106558 , 2024 2024 Citations: 35
Tyr352 as a predominant phosphosite in the understudied kinase and molecular target, HIPK1: implications for cancer therapy D Sanjeev, M George, L John, AP Gopalakrishnan, P Priyanka, S Mendon, ... OMICS: A Journal of Integrative Biology 28 (3), 111-124 , 2024 2024 Citations: 19
Cisplatin and procaterol combination in gastric cancer? Targeting checkpoint kinase 1 for cancer drug discovery and repurposing by an integrated computational and experimental … S Giridhara Prema, J Chandrasekaran, S Kanekar, M George, ... OMICS: A Journal of Integrative Biology 28 (1), 8-23 , 2024 2024 Citations: 3
Calcium/calmodulin-dependent protein kinase kinase 2 (CAMKK2) inhibitors: a novel approach in small molecule discovery R Devasahayam Arokia Balaya, J Chandrasekaran, S Kanekar, ... Journal of Biomolecular Structure and Dynamics 41 (24), 15196-15206 , 2023 2023 Citations: 3
Pleotropic potential of quorum sensing mediated N-acyl homoserine lactones (AHLs) at the LasR and RhlR receptors of Pseudomonas aeruginosa DAB Rex, K Saptami, J Chandrasekaran, PD Rekha Structural Chemistry 34 (4), 1327-1339 , 2023 2023 Citations: 13
Computational design of Novel Casein kinase 2 small molecule inhibitors for cancer therapy KP Gopalakrishna, K Gopinathan, REX DAB, S Kanekar, P Pavadai, ... 2023 Citations: 3
Computational design of Checkpoint Kinase-1 (CHK-1) inhibitors for cancer therapy J Chandrasekaran, S Kanekar, S Dagamajalu, P Modi, K Gopinathan, ... 2023 Citations: 1
MOST CITED SCHOLAR PUBLICATIONS
Chemical and biological evaluation of essential oils from cardamom species E Noumi, M Snoussi, MM Alreshidi, PD Rekha, K Saptami, L Caputo, ... Molecules 23 (11), 2818 , 2018 2018 Citations: 158
Potential synergistic activity of quercetin with antibiotics against multidrug-resistant clinical strains of Pseudomonas aeruginosa C Vipin, K Saptami, F Fida, M Mujeeburahiman, SS Rao, Athmika, ... PLoS one 15 (11), e0241304 , 2020 2020 Citations: 135
Microwave-assisted rapid synthesis of silver nanoparticles using fucoidan: Characterization with assessment of biocompatibility and antimicrobial activity SS Rao, K Saptami, J Venkatesan, PD Rekha International Journal of Biological Macromolecules 163, 745-755 , 2020 2020 Citations: 87
Antioxidant properties and anti-quorum sensing potential of Carum copticum essential oil and phenolics against Chromobacterium violaceum M Snoussi, E Noumi, R Punchappady-Devasya, N Trabelsi, S Kanekar, ... Journal of food science and technology 55 (8), 2824-2832 , 2018 2018 Citations: 79
Synthesis, characterization, antibacterial and antioxidant studies of some heterocyclic compounds from triazole‐linked chalcone derivatives R Santosh, MK Selvam, SU Kanekar, GK Nagaraja ChemistrySelect 3 (23), 6338-6343 , 2018 2018 Citations: 71
A medicinal herb Cassia alata attenuates quorum sensing in Chromobacterium violaceum and Pseudomonas aeruginosa PD Rekha, HS Vasavi, C Vipin, K Saptami, AB Arun Letters in Applied Microbiology 64 (3), 231-238 , 2017 2017 Citations: 53
Genome analysis of a halophilic bacterium Halomonas malpeensis YU-PRIM-29 T reveals its exopolysaccharide and pigment producing capabilities Athmika, SD Ghate, AB Arun, SS Rao, STA Kumar, MK Kandiyil, ... Scientific Reports 11 (1), 1749 , 2021 2021 Citations: 37
A global phosphosite-correlated network map of Thousand And One Kinase 1 (TAOK1) P Priyanka, AP Gopalakrishnan, M Nisar, PB Shivamurthy, M George, ... The International Journal of Biochemistry & Cell Biology 170, 106558 , 2024 2024 Citations: 35
Design, synthesis, DNA binding, and docking studies of Thiazoles and Thiazole‐containing Triazoles as antibacterials R Santosh, MK Selvam, SU Kanekar, GK Nagaraja, M Kumar ChemistrySelect 3 (14), 3892-3898 , 2018 2018 Citations: 30
Athmika; Arun, AB; Rekha, PD Potential synergistic activity of quercetin with antibiotics against multidrug-resistant clinical strains of Pseudomonas aeruginosa C Vipin, K Saptami, F Fida, M Mujeeburahiman, SS Rao PLoS One 15, e0241304 , 2020 2020 Citations: 27
Tyr352 as a predominant phosphosite in the understudied kinase and molecular target, HIPK1: implications for cancer therapy D Sanjeev, M George, L John, AP Gopalakrishnan, P Priyanka, S Mendon, ... OMICS: A Journal of Integrative Biology 28 (3), 111-124 , 2024 2024 Citations: 19
Competitive interaction of thymol with cviR inhibits quorum sensing and associated biofilm formation in Chromobacterium violaceum K Saptami, D Arokia Balaya Rex, J Chandrasekaran, PD Rekha International Microbiology 25 (3), 629-638 , 2022 2022 Citations: 19
Computational tools for exploring peptide-membrane interactions in gram-positive bacteria S Kumar, RDA Balaya, S Kanekar, R Raju, TSK Prasad, RK Kandasamy Computational and Structural Biotechnology Journal 21, 1995-2008 , 2023 2023 Citations: 18
Plant growth promoting bacteria induce anti-quorum-sensing substances in chickpea legume seedling bioassay A Saral, S Kanekar, KK Koul, SS Bhagyawant Physiology and Molecular Biology of Plants 27 (7), 1577-1595 , 2021 2021 Citations: 17
Isoeugenol suppresses multiple quorum sensing regulated phenotypes and biofilm formation of Pseudomonas aeruginosa PAO1 RP Shastry, S Kanekar, AS Pandial, PD Rekha Natural product research 36 (6), 1663-1667 , 2022 2022 Citations: 15
Pleotropic potential of quorum sensing mediated N-acyl homoserine lactones (AHLs) at the LasR and RhlR receptors of Pseudomonas aeruginosa DAB Rex, K Saptami, J Chandrasekaran, PD Rekha Structural Chemistry 34 (4), 1327-1339 , 2023 2023 Citations: 13
Carvone – a quorum sensing inhibitor blocks biofilm formation in Chromobacterium violaceum S Kanekar, F Fathima, PD Rekha Natural Product Research 36 (17), 4540-4545 , 2022 2022 Citations: 13
Growth-phase specific regulation of cvi I/R based quorum sensing associated virulence factors in Chromobacterium violaceum by linalool, a monoterpenoid S Kanekar, RP Devasya World Journal of Microbiology and Biotechnology 38 (2), 23 , 2022 2022 Citations: 13
Role of DEAD/DEAH-box helicases in immunity, infection and cancers R Devasahayam Arokia Balaya, S Kanekar, S Kumar, RK Kandasamy Cell Communication and Signaling 23 (1), 292 , 2025 2025 Citations: 12
Linalool-encapsulated alginate microspheres as anti-virulence target against wound infections using In vitro and In vivo models S Kanekar, SS Rao, S Yuvarajan, S Surya, PD Rekha Journal of Drug Delivery Science and Technology 77, 103848 , 2022 2022 Citations: 12
